Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20063307HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20035397HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20035398HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20018252HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20019409HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20019410HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20019411HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20020737HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20063427HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20063428HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TCGA Plot Options
Drug Information
GeneCD274
DrugBank IDDB14776
Drug NameCamrelizumab
Target IDBE0003441
UniProt IDQ9NZQ7
Regulation Typeinhibitor
PubMed IDs33807678
CitationsKyriakidis I, Vasileiou E, Rossig C, Roilides E, Groll AH, Tragiannidis A: Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies. J Fungi (Basel). 2021 Mar 5;7(3). pii: jof7030186. doi: 10.3390/jof7030186.
GroupsInvestigational
Direct Classification
SMILES
Pathways
PharmGKB
ChEMBL